Elekta included in FTSE4Good Index Series

Stockholm, October 8, 2014 – Elekta has been added to the FTSE4Good Index
Series (http://www.ftse.com/products/indices/FTSE4Good). This is a set of
indices defined by the FTSE that measures the performance of companies
demonstrating strong environmental, social and governance (ESG) practices.
Launched in 2001, the index is designed for use in the creation of index
tracking funds, derivatives and as a performance benchmark. This is the first
year that Elekta has been included.

Brittmarie Djurle, Global Vice President, CSR & Risk Management, at Elekta,
says: “We are proud to receive recognition for our ESG efforts. Being included
in the FTSE4Good Index Series is an acknowledgement of the progress we are
making in, for example, implementing Code of Conduct and Anti-Corruption
guidelines, enforcing labor standards as well as becoming more environmentally
sustainable.

Index governance is overseen by the independent FTSE4Good Advisory Committee,
made up of leading global responsible investment market practitioners and
experts in the principles and criteria use for determining the social
responsibility of corporate entities.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on October 8, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.